The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Adma Biologics Inc shares valued at $166,189 were sold by Guiheen Lawrence P. on Sep 09 ’24. At $18.47 per share, Guiheen Lawrence P. sold 9,000 shares. The insider’s holdings dropped to 153,941 shares worth approximately $2.99 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Guiheen Lawrence P. purchased 9,000 shares, netting a total of over 146,340 in proceeds.
Before that, Kestenberg-Messina Kaitlin M. had sold 24,150 shares from its account. In a trade valued at $408,050, the COO and SVP, Compliance traded Adma Biologics Inc shares for $16.90 each. Upon closing the transaction, the insider’s holdings decreased to 24,150 shares, worth approximately $8.73 million.
Analysts at Mizuho started covering the stock with ‘”a Buy”‘ outlook in a report released in mid October. As of November 11, 2021, Raymond James has increased its “an Outperform” rating to a “Strong buy” for ADMA. Earlier on November 09, 2021, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for ADMA stock.
Analyzing ADMA Stock Performance
During the last five days, there has been a drop of approximately -1.52%. Over the course of the year, Adma Biologics Inc shares have jumped approximately 330.09%. Shares of the company reached a 52-week high of $20.16 on 09/20/24 and a 52-week low of $4.37 on 01/03/24. A 50-day SMA is recorded $16.18, while a 200-day SMA reached $9.38. Nevertheless, trading volume fell to 5.36 million shares from 6.65 million shares the previous day.
Support And Resistance Levels for Adma Biologics Inc (ADMA)
According to the 24-hour chart, there is a support level at 19.11, which, if violated, would cause prices to drop to 18.77. In the upper region, resistance lies at 19.77. The next price resistance is at 20.09. RSI (Relative Strength Index) is 63.16 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.66, which suggests the price will decrease in the coming days. Percent R is at 22.15%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
